Clinical trial Recruiting at 12 sites Interventional Ages 18 to 99

Comparing OCT guidance to angiography for treating coronary in-stent restenosis

Official title: IN-Stent RestenosIs Detection and TrEtment by Optical Coherence Tomography

Run by San Luigi Gonzaga Hospital · NCT06779110 · Data updated 2026-11-12

This study is testing whether using a special imaging technique called OCT can help treat patients with blocked heart stents better than the usual method of using angiography.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment360 (estimated)
SponsorSan Luigi Gonzaga Hospital
Academic / other
Locations12 sites (Aosta, Aosta and 11 other locations)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2028
Registry record updatedJanuary 16, 2025
Trial IDNCT06779110 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with significant coronary in-stent restenosis suitable for PCI.

Probably not a fit

Patients unable to provide informed consent or those with technical limitations for OCT may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effectiveness of using optical coherence tomography (OCT) guidance versus traditional angiography guidance for percutaneous coronary intervention (PCI) in patients with coronary in-stent restenosis. Patients with significant restenosis will be randomly assigned to receive either OCT-guided PCI or angiography-guided PCI. The study aims to determine if OCT can improve outcomes in treating this condition, which remains a challenge despite advancements in stent technology. The trial will involve multiple centers and will assess the acute performance of the interventions.

Why it matters

Potential benefit: If successful, this approach could lead to improved treatment outcomes for patients with coronary in-stent restenosis.

How similar studies have gone: While OCT has shown promise in other cardiac interventions, its specific application in treating in-stent restenosis is still being explored, making this a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent signed
* Age ≥ 18 years
* Referred for angiography either in stable or ACS setting suitability for PCI through femoral or radial access
* A coronary in-stent restenosis between 70% and 99% in at least two projections in a vessel with a lumen diameter ≥ 2.25 - ≤ 5.75 mm (The severity of the stenosis should be based on visual estimation, with current online state-of-the-art angiographic equipment of the participating centres and after a mandatory dose of 50-200 mcg intracoronary of nitroglycerine.
* Stable hemodynamics

Exclusion Criteria:

* Inability to give informed consent
* Participation in another clinical study with an investigational product
* OCT pullback not technically feasible in vessel site

Where it's running

  • Osp Aosta
    Aosta, Aosta, Italy
    Recruiting
  • Biella
    Biella, Biella, Italy
    Recruiting
  • Osp. S. Croce e Carle
    Cuneo, Cuneo, Italy
    Recruiting
  • Ospedale Universitario di Ferrara
    Cona, Ferrara, Italy
    Recruiting
  • Osp Universitario S. Marino
    Genova, Genova, Italy
    Recruiting
  • Infermi Hospital, Rivoli ASLTO3
    Rivoli, Italy, Italy
    Recruiting
Show 6 more locations
  • Ospedale di Trapani
    Trapani, Trapani, Italy
    Recruiting
  • AOU San Luigi Gonzaga
    Orbassano, Turin, Italy
    Recruiting
  • AO Mauriziano
    Turin, Turin, Italy
    Recruiting
  • AOU Città della Salute e della Scienza
    Turin, Turin, Italy
    Recruiting
  • Osp. Giovanni Bosco
    Turin, Turin, Italy
    Recruiting
  • Osp Vercelli
    Vercelli, Vercelli, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.